HDTs
Human Digital Twins in Biopharma — The Future is Already Here
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-12Jun 26, 2025
Gene Editing
What are the key ethical and regulatory considerations as gene editing technologies advance toward widespread clinical use?
Pharma's Almanac
PAO-05-25-RT-02Jun 17, 2025
Oversight
All That Glitters Is Not Gold Standard Science
David Alvaro, Ph.D.; April Stanley, MS MBA; Sophie Lutter, Ph.D.
Pharma's Almanac
PAO-06-25-NI-02Jun 04, 2025
COVID-19
Rethinking Pharma’s Responsibilities in a Time of Crisis
Tim Tyson
TriRx Pharmaceutical Services
PAP-Q2-20-CL-001Jul 01, 2020
Nice Insight Overview
Pharma Tackles the Big Issues
Nigel Walker
Nice Insight
PAP-Q1-2019-NI-003Mar 12, 2019
Drug Pricing
Balancing Ethical and Fiduciary Responsibilities in Drug Pricing
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q1-2019-NI-004Mar 12, 2019
Clinical Trials
Evolving Ethical Conduct Concerns in Clinical Trials
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q1-2019-NI-005Mar 12, 2019
Ethical Business Practices
Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?
Pharma's Almanac
PAP-Q1-2019-NI-001Mar 12, 2019